Skip to content
2000
Volume 3, Issue 2
  • ISSN: 2405-4615
  • E-ISSN: 2405-4623

Abstract

Nanoliposomes, or submicron bilayer phospholipid vesicles, are a novel tool to encapsulate and deliver the active pharmaceutical ingredients. The listing of active substances for integration into nanoliposomes is enormous, varying from pharmaceuticals to nutraceuticals and cosmetics. Due to their biocompatible and biodegradable nature, besides their nanosize, nanoliposomes have applications in diverse areas, like cancer nanotherapy, cosmetics, gene delivery and agricultural food technology. Nanoliposomes have the capability of improving the efficacy of active agents by recuperating there in vitro-in vivo solubility, bioavailability, stability and prevent unnecessary interactions between molecules. Targeting by nanoliposomes depends on the types of the cells to achieve active drug concentrations for favorable therapeutic effectiveness at the desired target site and minimizing undesirable effects on healthy tissues and cells. This article sums up the existing studies that have described the nanoliposomal particles as carriers to transport a variety of pharmaceutical agents, properties, methods of preparation, and analysis.

Loading

Article metrics loading...

/content/journals/cnm/10.2174/2405461503666180821093033
2018-08-01
2025-09-13
Loading full text...

Full text loading...

/content/journals/cnm/10.2174/2405461503666180821093033
Loading

  • Article Type:
    Review Article
Keyword(s): Docetaxel; doxorubicin; gene delivery; magnetic; nanoliposome; PEG; tumor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test